Immuron CEO, Steven Lydeamore to present at H.C. Wainwright
11 September 2023 - 8:00PM
Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and
globally integrated biopharmaceutical company is pleased to advise
our Chief Executive Officer, Steven Lydeamore will be presenting
virtually at the H.C. Wainwright 25th Annual Global Investment
Conference on September 11th.
The webcast to this presentation will be
available here at 7am Eastern Daylight Time / 9pm Australian
Eastern Standard time on September 11th.
A copy of the presentation being made at the
H.C. Wainwright 25th Annual Global Investment Conference is
available on the Company’s website.
https://www.immuron.com.au/corporate-presentations/
This release has been
authorised by the directors of Immuron Limited.
COMPANY
CONTACT:
Steven
LydeamoreChief Executive OfficerPh: +61 (0)3 9824
5254info@immuron.com
About ImmuronImmuron Limited
(ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical
company focused on developing and commercialising orally delivered
targeted polyclonal antibodies for the treatment of infectious
diseases.
For more information visit:
http://www.immuron.com
Immuron (NASDAQ:IMRN)
Historical Stock Chart
From Apr 2024 to May 2024
Immuron (NASDAQ:IMRN)
Historical Stock Chart
From May 2023 to May 2024